Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey
Open Access
- 26 September 2001
- journal article
- Published by Springer Nature in Critical Care
- Vol. 5 (6) , 336-342
- https://doi.org/10.1186/cc1066
Abstract
Venous thromboembolism (VTE) confers considerable morbidity and mortality in hospitalized patients, although few studies have focused on the critically ill population. The objective of this study was to understand current approaches to the prevention and diagnosis of deep venous thrombosis (DVT) and pulmonary embolism (PE) among patients in the intensive care unit (ICU). Mailed self-administered survey of ICU Directors in Canadian university affiliated hospitals. Of 29 ICU Directors approached, 29 (100%) participated, representing 44 ICUs and 681 ICU beds across Canada. VTE prophylaxis is primarily determined by individual ICU clinicians (20/29, 69.0%) or with a hematology consultation for challenging patients (9/29, 31.0%). Decisions are usually made on a case-by-case basis (18/29, 62.1%) rather than by preprinted orders (5/29, 17.2%), institutional policies (6/29, 20.7%) or formal practice guidelines (2/29, 6.9%). Unfractionated heparin is the predominant VTE prophylactic strategy (29/29, 100.0%) whereas low molecular weight heparin is used less often, primarily for trauma and orthopedic patients. Use of pneumatic compression devices and thromboembolic stockings is variable. Systematic screening for DVT with lower limb ultrasound once or twice weekly was reported by some ICU Directors (7/29, 24.1%) for specific populations. Ultrasound is the most common diagnostic test for DVT; the reference standard of venography is rarely used. Spiral computed tomography chest scans and ventilation–perfusion scans are used more often than pulmonary angiograms for the diagnosis of PE. ICU Directors recommend further studies in the critically ill population to determine the test properties and risk:benefit ratio of VTE investigations, and the most cost-effective methods of prophylaxis in medical–surgical ICU patients. Unfractionated subcutaneous heparin is the predominant VTE prophylaxis strategy for critically ill patients, although low molecular weight heparin is prescribed for trauma and orthopedic patients. DVT is most often diagnosed by lower limb ultrasound; however, several different tests are used to diagnose PE. Fundamental research in critically ill patients is needed to help make practice evidence-based.Keywords
This publication has 46 references indexed in Scilit:
- Introduction to the Margaux Conference on Critical Illness: Activation of the coagulation system in critical illnessesCritical Care Medicine, 2000
- Comparison of Open and Closed Questionnaire Formats in Obtaining Demographic Information From Canadian General InternistsJournal of Clinical Epidemiology, 1999
- Efficacy and Safety of Low Molecular Weight Heparin, Unfractionated Heparin and Warfarin for Thrombo-Embolism Prophylaxis in Orthopaedic Surgery: A Meta-Analysis of Randomised Clinical TrialsPathophysiology of Haemostasis and Thrombosis, 1997
- A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major TraumaNew England Journal of Medicine, 1996
- Prevalence of Acute Pulmonary Embolism Among Patients in a General Hospital and at AutopsyChest, 1995
- A Prospective Study of Venous Thromboembolism after Major TraumaNew England Journal of Medicine, 1994
- Venous Thromboses and Pulmonary Embolisms in Post-mortem Series: Probable Causes by Correlations of Clinical Data and Basic DiseasesPathology - Research and Practice, 1994
- Interviewer versus self-administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthmaJournal of Clinical Epidemiology, 1993
- Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.BMJ, 1992
- High risk of the critically ill for venous thromboembolismCritical Care Medicine, 1982